New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2014
13:25 EDTILMN, ILMN, ILMN, LMNX, LMNX, LMNX, CPHD, CPHD, CPHD, GNMK, GNMK, GNMK, NSTG, NSTG, NSTG, MYGN, MYGN, MYGN, FLDM, FLDM, FLDM, PACB, PACB, PACB, TMO, TMO, TMO, QGEN, QGEN, QGENLeerink's life science tools analyst holds an analyst/industry conference call
Life Science Tools Analyst Leonard discusses the use of nextgen sequencing in a clinical context, early applications and uptake, the merits, demerits of various nextgen sequencing instruments and where new offerings fit on an Analyst/Industry conference call. Relevant companies ILMN, TMO, PACB, FLDM, MYGN, NSTG, GNMK, CPHD, LMNX and QGEN may be discussed on the Analyst/Industry conference call to be held on April 3 at 2 pm.
News For ILMN;TMO;PACB;FLDM;MYGN;NSTG;GNMK;CPHD;LMNX;QGEN From The Last 14 Days
Check below for free stories on ILMN;TMO;PACB;FLDM;MYGN;NSTG;GNMK;CPHD;LMNX;QGEN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 18, 2014
09:44 EDTCPHDCepheid trades sharply lower after earnings, levels to watch
Subscribe for More Information
09:24 EDTCPHDOn The Fly: Pre-market Movers
Subscribe for More Information
July 17, 2014
17:42 EDTCPHDCepheid says Roche patent suit will not have material adverse impact on results
Subscribe for More Information
17:31 EDTCPHDCepheid sees significant step up in Q4 revenue
17:31 EDTCPHDCepheid sees Q3 non-GAAP EPS (1c)-1c, consensus (8c)
Subscribe for More Information
16:14 EDTCPHDCepheid sees FY14 adjusted EPS 10c-13c, may not compare to consensus (37c)
Subscribe for More Information
16:13 EDTCPHDCepheid reports Q2 EPS (14c), consensus (14c)
Reports Q2 revenue $116.5M, consensus $115.56M.
10:00 EDTTMO, ILMNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:02 EDTTMOThermo Fisher to sell Cole-Palmer to GTCR for $480M in cash
Thermo Fisher Scientific has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR, LLC for $480M in cash. Thermo Fisher anticipates closing the transaction in Q3, subject to customary closing conditions and applicable regulatory approvals. The company expects an immaterial impact to 2014 adjusted EPS and will update annual guidance in its Q2 earnings release on July 23.
06:21 EDTTMOThermo Fisher initiated with a Buy at Citigroup
Target $137.
06:20 EDTILMNIllumina initiated with a Buy at Citigroup
Subscribe for More Information
July 16, 2014
11:28 EDTTMOLeon Cooperman gives 12 stock picks at CNBC conference
Subscribe for More Information
06:31 EDTILMNIllumina acquires Myraqa
Subscribe for More Information
July 15, 2014
16:05 EDTQGENQIAGEN launches 14 new cancer gene panels
Subscribe for More Information
July 14, 2014
08:18 EDTCPHDCepheid Q2 results should beat expectations, says Wedbush
Wedbush thinks the high number of Cepheid's Infinity placements in 4Q13 and Q1 could boost the company's Q2 results. The firm keeps a $58 price target and Outperform rating on the shares.
July 12, 2014
16:18 EDTILMNIllumina selected by UK for genome sequencing, Bloomberg says
Subscribe for More Information
July 10, 2014
10:59 EDTFLDMFluidigm expected to report strong quarter at Piper Jaffray
Subscribe for More Information
10:05 EDTQGEN, CPHDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
July 9, 2014
16:41 EDTQGENQIAGEN initiated with a Market Perform at Wells Fargo
Subscribe for More Information
16:40 EDTCPHDCepheid initiated with an Outperform at Wells Fargo
Price target range $56-$58.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use